UBS Adjusts Price Target on Molina Healthcare to $180 From $151, Maintains Neutral Rating

robot
Abstract generation in progress

UBS has increased its price target for Molina Healthcare (MOH) to $180 from $151, while choosing to maintain a “Neutral” rating on the stock. This adjustment reflects an updated valuation for the managed healthcare provider. The article also notes that Deutsche Bank similarly adjusted its price target for Molina Healthcare earlier the same day.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin